Arestin - Use in Subjects With Peri-Implantitis

PHASE3CompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

June 30, 2014

Conditions
Peri-Implantitis
Interventions
DRUG

Minocycline HCl Microspheres

Trial Locations (12)

21201

University of Maryland, School of Dentistry, Baltimore

22101

The Periodontal-Implant Institute, McLean

27599

University of North Carolina, General Oral Health Center, Chapel Hill

30912

Georgia Regents University, Augusta

32610

University of Florida College of Dentistry, Gainsville

40225

University of Dusseldorf, Poliklinik fur Zahnerhaltung, Parodontologie und Endodontologie, Düsseldorf

43210

Ohio State University College of Dentistry, Columbus

55355

University of Minnesota - School of Dentistry, Minneapolis

90095

UCLA School of Dentistry - Oral and Maxillofacial Surgery, Los Angeles

98195-7444

University of Washington, School of Dentistry, Seattle

SE-291 88

Kristianstad University, Department of Periodontology, Kristianstad

WC1X 8LD

Eastman Dental Institute, University College of London, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

OraPharma

INDUSTRY

NCT01539564 - Arestin - Use in Subjects With Peri-Implantitis | Biotech Hunter | Biotech Hunter